Semnur Pharmaceuticals, Inc. - SMNR

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2023 · Q2 2023
Value (USD)
Total reported value ($000)
$42.71M
QoQ value delta ($000)
-$3.8M (-8.17%)
Implied price effect (QoQ)
+2.14%
Shares
Total shares
3,904,432
QoQ shares delta
-438,210 (-10.09%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SMNR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2023)

Top 25 only Full list
Early Q1 2025 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Hudson Bay Capital Management LP 5,460 500,000 0.04%
WOLVERINE ASSET MANAGEMENT LLC 5,302 484,287 0.06%
BOOTHBAY FUND MANAGEMENT, LLC 5,146 470,000 0.12%
Saba Capital Management, L.P. 4,489 410,000 0.11%
Calamos Advisors LLC 3,822 350,000 0.02%
Context Capital Management, LLC 3,340 305,000 0.27%
Polar Asset Management Partners Inc. 3,285 300,000 0.07%
Starboard Value LP 3,285 300,000 0.08%
D. E. Shaw & Co., Inc. 2,457 225,000 0.0%
WHITEBOX ADVISORS LLC 2,190 200,000 0.07%
Centiva Capital, LP 2,050 187,764 0.05%
AQR Arbitrage LLC 1,770 162,177 0.08%
Dakota Wealth Management 109 10,000 0.0%
Tower Research Capital LLC (TRC) 2 204 0.0%